Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men

Diabetologia

Volumn 51, Issue 1, 2008, Pages 139-146

  Xiao, C ^a   Giacca, A ^a   Lewis, G F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Antioxidants; Human; Insulin resistance; Insulin secretion; Lipid

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; FATTY ACID; HEPARIN; INSULIN; INTRALIPID; MALONALDEHYDE; SODIUM CHLORIDE; TAURINE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; DRUG INFUSION; FATTY ACID BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ADULT; DIABETES MELLITUS; FATTY ACIDS, NONESTERIFIED; FREE RADICAL SCAVENGERS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LIPIDS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; TAURINE;

EID: 36649012405     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0859-x     Document Type: Article

References (42)

1. Gerich JE (2003) Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447-456
2. Kahn SE (2000) The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 108(Suppl 6a):2S-8S
3. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
4. Polonsky KS (1995) Lilly lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705-717
5. Porte D Jr (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40:166-180
6. Boden G, Ruiz J, Kim CJ, Chen X (1996) Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol 270:E251-E258
7. Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863-870
8. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055-E1066
9. Carpentier A, Zinman B, Leung N et al (2003) Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes. Diabetes 52:1485-1495
10. Leung N, Sakaue T, Carpentier A, Uffelman K, Giacca A, Lewis GF (2004) Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 47:204-213
11. Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242
12. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF (2000) Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399-408
13. Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167-179
14. Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-2011
15. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-867
16. Ozcan U, Cao Q, Yilmaz E et al (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461
17. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622
18. Robertson RP (2006) Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 6:615-619
19. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC (2002) Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277:30010-30018
20. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145:5087-5096
21. Paolisso G, Gambardella A, Tagliamonte MR et al (1996) Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab 81:4244-4248
22. Haber CA, Lam TK, Yu Z et al (2003) N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285:E744-E753
23. Kaneto H, Kajimoto Y, Miyagawa J et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48:2398-2406
24. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M (2000) Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54-58
25. Oprescu AI, Bikopoulos G, Naassan A et al (2007) Free fatty acid-induced reduction in glucose stimulated insulin secretion evidence for a role of oxidative stress in vitro and in vivo. Diabetes DOI 10.2337/db07-0075
26. De Mattia G, Bravi MC, Laurenti O et al (1998) Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin- dependent diabetes mellitus. Metabolism 47:993-997
27. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
28. Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC (1995) Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem 228:294-298
29. Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-85
30. Penttila KE (1990) Role of cysteine and taurine in regulating glutathione synthesis by periportal and perivenous hepatocytes. Biochem J 269:659-664
31. Beetsch JW, Olson JE (1998) Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure. Am J Physiol 274:C866-C874
32. Paolisso G, D'Amore A, Di Maro G et al (1993) Evidence for a relationship between free radicals and insulin action in the elderly. Metabolism 42:659-663
33. Paolisso G, D'Amore A, Volpe C et al (1994) Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 43:1426-1429
34. Paolisso G, Giugliano D (1996) Oxidative stress and insulin action: is there a relationship? Diabetologia 39:357-363
35. Boden G, She P, Mozzoli M et al (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54:3458-3465
36. Cotgreave IA (1997) N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 38:205-227
37. De Caro L, Ghizzi A, Costa R, Longo A, Ventresca GP, Lodola E (1989) Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers. Arzneimittelforschung 39:382-386
38. Sjodin K, Nilsson E, Hallberg A, Tunek A (1989) Metabolism of N-acetyl-l-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability. Biochem Pharmacol 38:3981-3985
39. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
40. Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
41. Brons C, Spohr C, Storgaard H, Dyerberg J, Vaag A (2004) Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 58:1239-1247
42. Lupi R, Del Guerra S, Fierabracci V et al (2002) Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes 51(Suppl 1):S134-S137